| Year |
Citation |
Score |
| 2021 |
Cunningham JI, Todtenkopf MS, Dean RL, Azar MR, Koob GF, Deaver DR, Eyerman DJ. Samidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar rats. Pharmacology, Biochemistry, and Behavior. 173157. PMID 33647274 DOI: 10.1016/j.pbb.2021.173157 |
0.75 |
|
| 2020 |
Ferdousi MI, Calcagno P, Clarke M, Aggarwal S, Sanchez C, Smith KL, Eyerman DJ, Kelly JP, Roche M, Finn DP. Hyporesponsivity to mu-opioid receptor agonism in the Wistar-Kyoto rat model of altered nociceptive responding associated with negative affective state. Pain. PMID 32826755 DOI: 10.1097/j.pain.0000000000002039 |
0.37 |
|
| 2019 |
Burke NN, Li Y, Deaver DR, Finn DP, Roche M, Eyerman DJ, Sanchez C, Kelly JP. Chronic administration of buprenorphine in combination with samidorphan produces sustained effects in olfactory bulbectomised rats and Wistar-Kyoto rats. Journal of Psychopharmacology (Oxford, England). 269881119872203. PMID 31512988 DOI: 10.1177/0269881119872203 |
0.428 |
|
| 2019 |
Cunningham JI, Eyerman DJ, Todtenkopf MS, Dean RL, Deaver DR, Sanchez C, Namchuk M. Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates. Journal of Psychopharmacology (Oxford, England). 269881119856850. PMID 31294646 DOI: 10.1016/j.euroneuro.2018.11.598 |
0.697 |
|
| 2019 |
Cunningham J, Eyerman D, Todtenkopf M, Dean R, Deaver D, Sanchez C, Namchuk M. P.125 Samidorphan, an opioid receptor antagonist, mitigates olanzapine-induced metabolic dysfunction in female rats European Neuropsychopharmacology. 29: S103-S104. DOI: 10.1016/j.euroneuro.2019.09.179 |
0.756 |
|
| 2019 |
Smith K, Deaver D, Dean R, Cunningham J, Sanchez C, Eyerman D. Mu dependent effects of buprenorphine in combination with samidorphan on immobility behavior in Wistar Kyoto rats European Neuropsychopharmacology. 29: S63-S64. DOI: 10.1016/j.euroneuro.2018.11.1041 |
0.744 |
|
| 2019 |
Cunningham J, Eyerman DJ, Todtenkopf M, Dean RL, Deaver DR, Sanchez C, Namchuk MN. F160. Samidorphan, an Opioid Receptor Antagonist, Mitigates Olanzapine-Induced Metabolic Dysfunction in Female Rats Biological Psychiatry. 85: S275. DOI: 10.1016/j.biopsych.2019.03.697 |
0.743 |
|
| 2018 |
Smith KL, Cunningham JI, Eyerman DJ, Dean RL, Deaver DR, Sanchez C. Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat. Neuropharmacology. PMID 30448421 DOI: 10.1016/j.neuropharm.2018.11.015 |
0.761 |
|
| 2015 |
Cunningham J, Smith K, Dean R, Deaver D, Eyerman D. P.2.a.016 The effects of buprenorphine in combination with samidorphan on neurochemical and behavioral measures in Wistar Kyoto rats European Neuropsychopharmacology. 25: S384. DOI: 10.1016/S0924-977X(15)30500-9 |
0.737 |
|
| 2014 |
Cunningham J, Dean R, Todtenkopf M, Azar M, Koob G, Deaver D, Eyerman D. P.3.a.009 Samidorphan attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in rats European Neuropsychopharmacology. 24: S489. DOI: 10.1016/S0924-977X(14)70782-5 |
0.726 |
|
| 2014 |
Todtenkopf M, Dean R, Eyerman D, Cunningham J, Deaver D. P.2.a.010 Buprenorphine in combination with samidorphan (ALKS 33) results in antidepressive-like effects in two distinct rat models European Neuropsychopharmacology. 24: S366-S367. DOI: 10.1016/S0924-977X(14)70585-1 |
0.734 |
|
| 2012 |
Dean RL, Eyerman D, Todtenkopf MS, Turncliff RZ, Bidlack JM, Deaver DR. Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats. Pharmacology, Biochemistry, and Behavior. 100: 530-7. PMID 22056608 DOI: 10.1016/j.pbb.2011.10.019 |
0.391 |
|
| 2011 |
Northrop NA, Smith LP, Yamamoto BK, Eyerman DJ. Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals. The Journal of Pharmacology and Experimental Therapeutics. 336: 900-7. PMID 21159748 DOI: 10.1124/Jpet.110.177287 |
0.684 |
|
| 2007 |
Eyerman DJ, Yamamoto BK. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. Journal of Neurochemistry. 103: 1219-27. PMID 17683483 DOI: 10.1111/J.1471-4159.2007.04837.X |
0.592 |
|
| 2005 |
Eyerman DJ, Yamamoto BK. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum. The Journal of Pharmacology and Experimental Therapeutics. 312: 160-9. PMID 15331654 DOI: 10.1124/Jpet.104.072264 |
0.641 |
|
| Show low-probability matches. |